Fig. 2From: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patientsOverall incidence of SAEs (a) and FAEs (b) associated with nivolumab treatment FAE, fatal adverse event; SAE, serious adverse eventBack to article page